[Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer]. / Einfluss der Komorbidität auf die Mortalität und Morbidität bei der radikalen Zystektomie.
Aktuelle Urol
; 46(3): 236-41, 2015 May.
Article
em De
| MEDLINE
| ID: mdl-26077308
ABSTRACT
Radical cystectomy (RC) with bilateral pelvic lymph node dissection constitutes the gold standard treatment for muscle-invasive and high-risk non-muscle-invasive urothelial carcinoma of the bladder refractory to instillation therapy. Although radical cystectomy is performed with curative intent, the overall 5-year survival has been reported to be as low as 62% in the current literature. Various clinico-pathological parameters determine post-RC outcome, but besides these, the role of comorbidity has gained increasing attention and can be quantified with various comorbidity scores. We here review the most recent data on comorbidity scores and performance indices, which have been assessed in patients, undergoing RC and highlight their clinical implications.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Bexiga Urinária
/
Carcinoma de Células Escamosas
/
Carcinoma de Células de Transição
/
Adenocarcinoma
/
Cistectomia
Idioma:
De
Ano de publicação:
2015
Tipo de documento:
Article